Stanford School of Medicine
 use browser back button to return
  •  
  • Surgical Pathology Criteria
    http://surgpathcriteria.stanford.edu/

    Mammary Hamartoma

    Definition

    • Sharply circumscribed breast mass composed of normal or fibrocystic appearing tissue

    Alternate/Historical Names

    • Adenolipoma (variant)
    • Choristoma
    • Fibroadenolipoma
    • Muscular or myoid hamartoma (variant)

    Diagnostic Criteria

    • Sharply circumscribed mass
      • Nearly always palpable or radiographically distinct
    • Composed of fibrous, fatty and glandular tissue
      • Fibrous tissue may be dense and keloid-like
      • Well formed ducts and lobules witih epithelial and myoepithelial cells
        • Ducts may be cystic
        • Lobules may be atrophic
        • Normall peripheral distribution of myoepithelial cells
      • Fat cells admixed
        • If fat is predominant, lesion may be termed Adenolipoma
          • No special clinical significance
      • Appearance may be indistinguishable from fibrocystic change
        • Circumscription is the only difference
      • Cells with smooth muscle differentiation may be seen
        • When smooth muscle cells are prominent, such lesions have been termed Myoid Hamartomas
          • Smooth muscle cells may be spindled or epithelioid
          • No special clinical significance
      • Pseudoangiomatous stromal hyperplasia (PASH) has been reported in 25/35 mamary hamartomas
      • Cartilage is rarely reported
        • May be considered metaplasia in a hamartoma
        • May be termed choristoma
      • One report of brown fat
      • Carcinoma has rarely been reported to involve mammary hamartomas
      • Simlar findings have been reported in Cowden disease
        • May be indistinguishable if circumscribed and solitary
        • More common if diffuse or bilateral

    Richard L Kempson MD
    Robert V Rouse MD
    Department of Pathology
    Stanford University School of Medicine
    Stanford CA 94305-5342

    Original posting:: May 15, 2006

    Supplemental studies

    Immunohistology

    • Actin, calponin, p63
      • Highlight myoepithelial cells with normal distribution
      • Actin may demonstrate smooth muscle cells in myoid hamartoma
    • CD34 may stain areas of PASH
    • CD34 reported to stain muscle cells of myoid hamaratoma

    Differential Diagnosis

    Nonspecific fibrocystic disease

    • Mammary hamartoma is distinguished only based on its circumscription and formation of a discrete mass

    Adenomyoepithelioma Myoid Hamartoma
    Myoepithelial component positive for keratin, p63, smooth muscle actin Myoid component positive only for smooth muscle actin
    Tubules without lobules Well formed ducts and lobules
    No admixed fat Admixed fat

    Cowden disease

    • May be indistinguishable if circumscribed and solitary
    • Diffuse or bilateral lesions favor Cowden disease

    Fibroadenoma Mammary Hamartoma
    Lobules infrequent Lobules typically present (may be atrophic)
    Frequent intracanalicular or tubular glandular proliferation Morphologically normal ducts and lobules
    Intralesional fat rare Fat integral to lesion

    Diabetic Mastopathy / Lymphocytic Mastitis Mammary Hamartoma
    Epithelioid stromal cells No epithelioid stromal cells
    Prominent B cell infiltrates No significant B cell infiltrates
    Both have keloidal fibrosis

    Intramammary lipoma vs Adenolipoma

    • Ducts and lobules prominent in adenolipoma
    • Ducts and lobules rare or absent in lipoma
    • No clinical significance to the distinction

    Mammary Hamartoma Gynecomastia-like Lesion of the Female Breast
    Circumscribed Not circumscribed
    Contains lobules No lobules
    No periductal stromal changes Periductal stromal fibrosis or edema
    May contain stromal smooth muscle or cartilage No stromal smooth muscle or cartilage

    Clinical

    • Rare lesion, <1% of breast biopsies
    • Age range 18-89 but most premenopausal
    • Unilateral
    • Benign, infrequent recurrences reported
      • No special clinical significance to recognition of myoid or adenolipomatous variants
    • One male case of myoid hamartoma reported
    • One ectopic (inguinal) case reported
    • Nearly always a palpable or radiographically distinct mass

    Lists

    Breast Tumors and Lesions Exhibiting Reactivity for Muscle/Myoepithelial Markers

    (Most benign lesions with an epithelial component will have a myoepithelial cell layer)

    Bibliography

    • Oberman HA. Hamartomas and hamartoma variants of the breast. Semin Diagn Pathol. 1989 May;6(2):135-45.
    • Filho OG, Gordan AN, Mello Rde A, Neto CS, Heinke T. Myoid hamartomas of the breast: report of 3 cases and review of the literature. Int J Surg Pathol. 2004 Apr;12(2):151-3.
    • Ravakhah K, Javadi N, Simms R. Hamartoma of the breast in a man: first case report. Breast J. 2001 Jul-Aug;7(4):266-8.
    • Daroca PJ Jr, Reed RJ, Love GL, Kraus SD. Myoid hamartomas of the breast. Hum Pathol. 1985 Mar;16(3):212-9.
    • Chiacchio R, Panico L, D'Antonio A, Delrio P, Bifano D, Avallone M, Pettinato G. Mammary hamartomas: an immunohistochemical study of ten cases. Pathol Res Pract. 1999;195(4):231-6.
    • Garijo MF, Torio B, Val-Bernal JF. Mammary hamartoma with brown adipose tissue. Gen Diagn Pathol. 1997 Dec;143(4):243-6.
    • Rege JD, Shet TM, Pathak VM, Zurale DU. Mammary hamartomas--a report of 15 cases. Indian J Pathol Microbiol. 1997 Oct;40(4):543-8.
    • Daya D, Trus T, D'Souza TJ, Minuk T, Yemen B. Hamartoma of the breast, an underrecognized breast lesion. A clinicopathologic and radiographic study of 25 cases. Am J Clin Pathol. 1995 Jun;103(6):685-9.
    • Charpin C, Mathoulin MP, Andrac L, Barberis J, Boulat J, Sarradour B, Bonnier P, Piana L. Reappraisal of breast hamartomas. A morphological study of 41 cases. Pathol Res Pract. 1994 Apr;190(4):362-71.
    • Dworak O, Reck T, Greskotter KR, Kockerling F. Hamartoma of an ectopic breast arising in the inguinal region. Histopathology. 1994 Feb;24(2):169-71.
    • Fisher CJ, Hanby AM, Robinson L, Millis RR. Mammary hamartoma--a review of 35 cases. Histopathology. 1992 Feb;20(2):99-106.
    • Anani PA, Hessler C. Breast hamartoma with invasive ductal carcinoma. Report of two cases and review of the literature. Pathol Res Pract. 1996 Dec;192(12):1187-94.
    • Magro G, Bisceglia M. Muscular hamartoma of the breast. Case report and review of the literature. Pathol Res Pract. 1998;194(5):349-55.
    • Rameh-Rommani S, Sassi S, Mrad K, Khattech R, Ben Romdhane K. Chondrolipomatous tumor of the breast with myoid differentiation. Clin Exp Pathol. 1999;47(5):257-60.
    • Metcalf JS, Ellis B. Choristoma of the breast. Hum Pathol. 1985 Jul;16(7):739-40.
    • Harigopal M, Mudrovich SA, Hoda SA, Rosen PP. Secondary tumors in mammary adenolipomas: a report of 2 unusual cases. Arch Pathol Lab Med. 2003 Mar;127(3):e151-4.
    • Moore T, Lee AH. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast. Histopathology. 2001 Jan;38(1):62-7.
    Printed from Surgical Pathology Criteria: http://surgpathcriteria.stanford.edu/
    © 2005  Stanford University School of Medicine